Prevalence of gastrointestinal diseases in two British national birth cohorts

Ehlin, A.G.C.; Montgomery, S.M.; Ekbom, A.; Pounder, R.E.; Wakefield, A.J.
August 2003
Gut;Aug2003, Vol. 52 Issue 8, p1117
Academic Journal
Background: Few studies have investigated the prevalence of multiple gastrointestinal diseases in the general British population. Aim: To examine the prevalence of Crohn's disease (CD), ulcerative colitis (UC), irritable bowel syndrome (IBS), gall stones (GS), and peptic ulcer disease (PUD). Subjects: The 1970 British Cohort Study (BCS70) and the National Child Development Study (NCDS) are two one week national birth cohorts born in 1970 and 1958, respectively. All cohort members living in Great Britain were interviewed in 1999/2000. Methods: The prevalence rates of the five diseases were calculated, and associations with sex and childhood social class were investigated using logistic regression. Results: At age 30 years, the prevalence rates per 10 000 (95% confidence interval (CI)) in the 1970 and 1958 cohorts, respectively, were: CD 38 (26-49), 21 (13-30); UC 30 (20-41), 27 (18-37); IBS 826 (775-877), 290 (267-330); GS 88 (71-106), 78 (62-94); and PUD 244 (214-273), 229 (201-256). There was a significantly higher proportion with CD (p=0.023) and IBS (p=0.000) in the 1970 cohort compared with the 1958 cohort at age 30 years. Comparing the cohorts in the 1999/ 2000 sweep, UC, GS, and PUD were significantly (p=0.001, p=0.000, p=0.000) more common in the 1958 cohort. There was a statistically significant trend for a higher risk of GS with lower social class in both cohorts combined (p=0.027). Conclusion: The study indicates an increasing temporal trend in the prevalence of CD and suggests a period effect in IBS, possibly due to adult life exposures or variation in recognition and diagnosis of IBS.


Related Articles

  • The Ileum is the Major Site of Absorption of Vitamin B12 Analogues. Shaw, Spencer; Jayatilleke, Elizabeth; Meyers, Samuel; Colman, Neville; Herzlich, Barry; Herbert, Victor // American Journal of Gastroenterology;Jan1989, Vol. 84 Issue 1, p22 

    Non-cobalamin vitamin B12 analogues constitute a significant percentage of total corrinoids in human serum. The source and means of absorption of analogues and their significance are largely unknown. We studied the sites of production and absorption of B12 analogues by measuring serum vitamin...

  • Chronic diarrhoea. Spiller, R. // Gut;Dec2007, Vol. 56 Issue 12, p1756 

    The article offers information on the online tutorial entitled "Chronic diarrhoea" offered by the magazine. It states that diarrhoea or irritable bowel syndrome results to the development of abdominal pain and diarrhea among 20-40 year-old patients. It reveals that the attack of acute bacterial...

  • GASTROHEPATIC DISORDERS.  // MPR - Physician Assistants' Edition;Summer2015, Vol. 22 Issue 2, p82 

    The article offers information on drugs or medications indicated for gastrohepatic disorders. These include the prescription products like Anusol-HC Suppositories from Salix, Azulfidine EN-tabs from Pfizer and Cimzia tumor necrosis factor blocker from UCB. It cites the recommended dosages for...

  • Irritable Bowel Syndrome—Type Symptoms in Patients With Inflammatory Bowel Disease: A Real Association or Reflection of Occult Inflammation? Keohane, John; O'Mahony, Caitlin; O'Mahony, Liam; O'Mahony, Siobhan; Quigley, Eamonn M.; Shanahan, Fergus // American Journal of Gastroenterology;Aug2010, Vol. 105 Issue 8, p1789 

    OBJECTIVES:Do gastrointestinal symptoms in patients with inflammatory bowel disease (IBD) in apparent remission reflect the coexistence of irritable bowel syndrome (IBS) or subclinical inflammation? The aims of this study were as follows: (i) to prospectively determine the prevalence of IBS...

  • GASTROHEPATIC DISORDERS.  // MPR - Physician Assistants' Edition;Spring2015, Vol. 22 Issue 1, p80 

    The article reviews several drugs for gastrohepatic disorders including Amitiza from Sucampo and Takeda, Anusol-HC Suppositories from Salix and Asacol HD from Warner Chilcott.

  • CLINICAL EVALUATION OF MODIFIED SIRODHARA PROCEDURE & KUKSHI BASTI IN THE MANAGEMENT OF PAKVASAYAGATA VATA ROGA (IBS). Tripathi, J. S.; Byadgi, P. S.; Pramod // International Journal of Research in Ayurveda & Pharmacy;Sep2011, Vol. 2 Issue 5, p1416 

    Irritable Bowel Syndrome is a clinical entity recently identified with a set of symptoms related to gastrointestinal tract. These symptoms essentially pertain to the diathesis of gut motility disorder. The characteristic clinical features are abdominal pain, altered bowel habit, psychiatric...

  • GASTROHEPATIC DISORDERS.  // MPR - Nurse Practitioners' Edition;Summer2015, Vol. 22 Issue 2, p82 

    A list of pharmacologic products for gastro-hepatic disorders is presented, along with brief information about the drugs, including Amitiza tablets from Sucampo and Takeda, Asacol HD tablets from Warner Chilcott and Entocort EC capsules from AstraZeneca.

  • Alosetron in Irritable Bowel Syndrome. Lembo, Anthony; Weber, H. Christian; Farraye, Francis A. // Drugs;2003, Vol. 63 Issue 18, p1895 

    Irritable bowel syndrome (IBS) is a common gastrointestinal disorder characterised by recurrent abdominal pain and altered bowel habits in the absence of any discernible structural, biochemical and physiological abnormalities. Although there is no specific biological marker for the diagnosis of...

  • Linguistic Validation of the Irritable Bowel Syndrome-Quality of Life Questionnaire for Iranian Patients. Gholamrezaei, Ali; Zolfaghari, Behzad; Farajzadegan, Ziba; Nemati, Kianoosh; Daghaghzadeh, Hamed; Tavakkoli, Hamid; Emami, Mohammad Hassan // Acta Medica Iranica;2011, Vol. 49 Issue 6, p390 

    There is a growing interest of clinical and epidemiological researches in the field of functional gastrointestinal disorders in our society. Accordingly, validated and culturally adapted instruments are required for appropriate measurement of variables specially the quality of life. The aim of...


Read the Article


Sign out of this library

Other Topics